| Hizentra® in Inflammatory Neuropathies - pHeNIx Study (NCT04672733) | CSL Behring | 2022-06-10 |
| Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT03772717) | Emory University | 2022-02-22 |
| A Registered Cohort Study of Immune-Mediated Neuropathies (NCT04292834) | First Affiliated Hospital of Fujian Medical University | 2020-02-29 |
| NT-3 Levels and Function in Individuals With CMT (NCT05011006) | Zarife Sahenk | 2020-01-29 |
| Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP (NCT03779828) | CSL Behring | 2017-11-27 |
| SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study (NCT02967679) | MedDay Pharmaceuticals SA | 2016-12-05 |
| Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy (NCT02574962) | Mamatha Pasnoor, MD | 2015-08-01 |
| IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements (NCT02414490) | University of Minnesota | 2015-03-01 |
| IVIg for Demyelination in Diabetes Mellitus (NCT02372149) | University of Toronto | 2015-02-01 |
| Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT02465359) | University of South Florida | 2014-09-01 |
| Effect of Resistance and Aerobic Exercise in CIDP or MMN (NCT02121678) | University of Aarhus | 2014-04-01 |
| Immunoglobulin Dosage and Administration Form in CIDP and MMN (NCT02111590) | Rigshospitalet, Denmark | 2014-01-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy. (NCT01824251) | Nihon Pharmaceutical Co., Ltd | 2013-04-01 |
| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) (NCT01545076) | CSL Behring | 2012-03-01 |
| Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (NCT01379833) | State University of New York at Buffalo | 2011-05-01 |
| Study of Efficacy and Safety of Privigen in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (NCT01184846) | CSL Behring | 2010-11-01 |
| Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy (NCT00962429) | Oregon Health and Science University | 2009-02-01 |
| Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases (NCT00716066) | Fred Hutchinson Cancer Center | 2008-06-01 |
| Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy (NCT00278629) | Northwestern University | 2005-02-21 |
| High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy (NCT01236456) | Stony Brook University | 2003-10-01 |
| An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (NCT04825626) | Hope Biosciences Research Foundation | |